34033878|t|Beyond Lipoprotein(a) plasma measurements: Lipoprotein(a) and inflammation.
34033878|a|Genome wide association, epidemiological, and clinical studies have established high lipoprotein(a) [Lp(a)] as a causal risk factor for atherosclerotic cardiovascular disease (ASCVD). Lp(a) is an apoB100 containing lipoprotein covalently bound to apolipoprotein(a) [apo(a)], a glycoprotein. Plasma Lp(a) levels are to a large extent determined by genetics. Its link to cardiovascular disease (CVD) may be driven by its pro-inflammatory effects, of which its association with oxidized phospholipids (oxPL) bound to Lp(a) is the most studied. Various inflammatory conditions, such as rheumatoid arthritis (RA), systemic lupus erythematosus, acquired immunodeficiency syndrome, and chronic renal failure are associated with high Lp(a) levels. In cases of RA, high Lp(a) levels are reversed by interleukin-6 receptor (IL-6R) blockade by tocilizumab, suggesting a potential role for IL-6 in regulating Lp(a) plasma levels. Elevated levels of IL-6 and IL-6R polymorphisms are associated with CVD. Therapies aimed at lowering apo(a) and thereby reducing plasma Lp(a) levels are in clinical trials. Their results will determine if reductions in apo(a) and Lp(a) decrease cardiovascular outcomes. As we enter this new arena of available treatments, there is a need to improve our understanding of mechanisms. This review will focus on the role of Lp(a) in inflammation and CVD.
34033878	7	21	Lipoprotein(a)	Gene	4018
34033878	43	57	Lipoprotein(a)	Gene	4018
34033878	62	74	inflammation	Disease	MESH:D007249
34033878	161	175	lipoprotein(a)	Gene	4018
34033878	177	182	Lp(a)	Gene	4018
34033878	212	250	atherosclerotic cardiovascular disease	Disease	MESH:D050197
34033878	252	257	ASCVD	Disease	MESH:D050197
34033878	260	265	Lp(a)	Gene	4018
34033878	272	279	apoB100	Gene	338
34033878	323	340	apolipoprotein(a)	Gene	4018
34033878	342	348	apo(a)	Gene	4018
34033878	374	379	Lp(a)	Gene	4018
34033878	445	467	cardiovascular disease	Disease	MESH:D002318
34033878	469	472	CVD	Disease	MESH:D002318
34033878	499	511	inflammatory	Disease	MESH:D007249
34033878	551	573	oxidized phospholipids	Chemical	-
34033878	575	579	oxPL	Chemical	-
34033878	590	595	Lp(a)	Gene	4018
34033878	625	637	inflammatory	Disease	MESH:D007249
34033878	658	678	rheumatoid arthritis	Disease	MESH:D001172
34033878	680	682	RA	Disease	MESH:D001172
34033878	685	713	systemic lupus erythematosus	Disease	MESH:D008180
34033878	715	749	acquired immunodeficiency syndrome	Disease	MESH:D000163
34033878	755	776	chronic renal failure	Disease	MESH:D007676
34033878	802	807	Lp(a)	Gene	4018
34033878	828	830	RA	Disease	MESH:D001172
34033878	837	842	Lp(a)	Gene	4018
34033878	866	888	interleukin-6 receptor	Gene	3570
34033878	890	895	IL-6R	Gene	3570
34033878	909	920	tocilizumab	Chemical	MESH:C502936
34033878	954	958	IL-6	Gene	3569
34033878	973	978	Lp(a)	Gene	4018
34033878	1013	1017	IL-6	Gene	3569
34033878	1022	1027	IL-6R	Gene	3570
34033878	1062	1065	CVD	Disease	MESH:D002318
34033878	1095	1101	apo(a)	Gene	4018
34033878	1130	1135	Lp(a)	Gene	4018
34033878	1213	1219	apo(a)	Gene	4018
34033878	1224	1229	Lp(a)	Gene	4018
34033878	1414	1419	Lp(a)	Gene	4018
34033878	1423	1435	inflammation	Disease	MESH:D007249
34033878	1440	1443	CVD	Disease	MESH:D002318
34033878	Association	MESH:D000163	4018
34033878	Bind	338	4018
34033878	Negative_Correlation	MESH:C502936	3570
34033878	Negative_Correlation	MESH:C502936	4018
34033878	Association	MESH:D007249	4018
34033878	Association	3570	4018
34033878	Association	MESH:D007676	4018
34033878	Association	MESH:D001172	4018
34033878	Association	MESH:D002318	4018
34033878	Association	MESH:D002318	3570
34033878	Association	MESH:D050197	4018
34033878	Negative_Correlation	MESH:C502936	MESH:D001172
34033878	Association	3569	4018
34033878	Association	MESH:D008180	4018
34033878	Association	MESH:D002318	3569

